Xcyte Therapies' Unattributed VC - IV Round

Xcyte Therapies raised a round of funding on March 07, 2002.

Xcyte Therapies, development stage biotechnology company, develops therapeutic products that enhance the body's natural immune responses to treat cancer, infectious diseases, and other medical conditi…

Articles about Xcyte Therapies' Unattributed VC - IV Round: